Skip to main content

Table 4 Distribution of reminders by clinical condition and specific reminder in the intervention and control groups

From: Effectiveness of electronic point-of-care reminders versus monthly feedback to improve adherence to 10 clinical recommendations in primary care: a cluster randomized clinical trial

 Control group remindersIntervention group remindersTotal reminders
Clinical conditionType of reminderNo.%No.%No.%
Type 2 diabetes mellitusScreen for diabetic retinopathy34,7487.436,6497.571,3977.45
Measure glycated hemoglobin47,58210.1349,87310.297,45510.17
High blood pressureMeasure blood pressure22,038246.9423,055947.1745,094147.05
Atrial fibrillationTreat with antiplatelet drug/anticoagulant46500.9948520.9995020.99
Cerebrovascular accident/ischemic heart diseaseMeasure LDL cholesterol43,0329.1744,1969.0487,2289.1
Treat with antiplatelet drug98072.0910,4892.1520,2962.12
Heart failure/ischemic heart diseaseTreat with beta blocker32,8106.9934,3127.0267,1227
Heart failureTreat with ACEI/ARB71891.5377331.5814,9221.56
Hepatitis CHepatitis B vaccine86811.8585351.7517,2161.8
SmokingEncourage smoking cessation60,63312.9161,61312.6122,24612.76
 Total469,514100488,811100958,325100
  1. Abbreviations: ACEI Angiotensin-converting enzyme inhibitor, ARB Angiotensin II receptor blocker, LDL Low-density lipoprotein